Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
about
Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumorsIntelligent design: combination therapy with oncolytic virusesThe status of gene therapy for brain tumorsOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeUltrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art.Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesOncolytic virotherapy using herpes simplex virus: how far have we come?Extracellular matrix macromolecules: potential tools and targets in cancer gene therapyCurrent Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Oncolytic virotherapy of canine and feline cancerOncolytic viruses as anticancer vaccinesTumor cell migration in complex microenvironmentsExploring the tumor microenvironment with nanoparticlesExtracellularly activatable nanocarriers for drug delivery to tumors.In vitro methods for evaluating therapeutic ultrasound exposures: present-day models and future innovations.Pulsed focused ultrasound exposures enhance locally administered gene therapy in a murine solid tumor model.Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids.Effect of ultrasound on herpes simplex virus infection in cell culture.Mutant sodium channel for tumor therapy.Ultrasound mediated delivery of drugs and genes to solid tumors.Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET.Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamstersEffect of antigen turnover rate and expression level on antibody penetration into tumor spheroids.Frontiers in cancer nanomedicine: directing mass transport through biological barriersTissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitorsStromal regulation of vessel stability by MMP14 and TGFbeta.Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.Impact of tumor microenvironment on oncolytic viral therapyStrategies for advancing cancer nanomedicine.EFFECTS OF POLYMERIC NANOPARTICLE SURFACE PROPERTIES ON INTERACTION WITH BRAIN TUMOR ENVIRONMENT.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronanDiffusion anisotropy in collagen gels and tumors: the effect of fiber network orientationA common neuronal response to alphaherpesvirus infection.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Multistage nanoparticle delivery system for deep penetration into tumor tissue.
P2860
Q24614856-D6057BDA-93AF-41BE-93CA-1C623F1826C5Q24628227-F072F11E-6148-43F0-A00C-56BF9CE74F21Q24651009-26931861-0B60-4764-A09E-0A498B03FB2EQ26769977-42CDDAB0-9803-46CF-ABC7-6F17178C96F6Q26827216-AFA94CE0-9A72-4C4B-8271-F395ECB2BC66Q26828930-99DC2413-26BF-41F1-A745-87480027E05AQ26862461-030B7F40-F766-4E0F-B11F-56166935BC12Q26996081-B8AE15DE-A999-4369-A81C-F44B8B48F37DQ27002209-4BACF3AF-32AA-48AD-A334-E730EEE870BCQ27008306-B7C298B6-89E2-4730-906C-0047F36726E1Q27025600-E89F026A-A60A-4DC3-8D26-943823850E03Q27027489-521A1D32-C659-45FE-9722-43518A84C80DQ28082374-165A0C17-8745-42D8-8334-3E94DE13452DQ30401826-2EC40FA4-6635-41C2-B636-8D0199CB71C7Q30433475-8B8F6DAB-ED50-4E5C-8ACB-CF3D23899864Q30442329-957B9E0C-D4D9-4AEC-8748-40FACBBCABB3Q30472417-23ABCEC8-B93A-4335-A2C7-1AC36EF6C3E7Q30473768-ADA2E087-E153-41D3-9B42-1425BEEE991DQ30481753-0EF4F983-D0A9-4746-8538-6BF0F4A22CE6Q30488681-A5FA3E59-4133-4E06-8FC1-299E08D75E28Q30493238-8C45B2E9-913E-4B66-970B-F15772A79076Q30525290-3E188A0F-9F72-48B6-AD64-5F1C713B436CQ30542073-DD824D06-9D7C-4570-A851-ECDD1EA962B1Q33416415-F402EFA1-7136-4534-8AF2-9437298FA85FQ33580223-4751D9A6-8B36-48F0-B10A-2AD44D646900Q33698791-7DC11274-4D09-4F07-AA32-EE542F507E40Q33746335-7EFED7BE-590A-4487-BAEF-3CE2CD5F4325Q33794302-DFC65FB8-D912-4A86-BB6E-15B2D5F0ABF9Q33815414-FE7B96F7-41D0-4283-8D6A-B9D6D46744A3Q33857937-1F8F2C98-D7B2-4D46-824A-5BBDB9BE5E99Q33895533-B15EE065-D7F7-4FCF-895D-2414F02CEE55Q33995719-8BB25EF7-7F9B-41AB-A461-AF72CE9C35CFQ34019320-8E1E84E1-B532-4590-8010-F01152A26D41Q34030709-9DFAA9C6-F7B0-4184-89D2-289185559ED8Q34046125-CCB4B219-41C7-4767-8A10-AF8B4A62693CQ34145464-8FC3C22D-CB20-423E-B041-191124960DCDQ34307013-E5847753-9B69-4A8E-925F-12F9ACED56F2Q34345562-CEDE57A9-A83F-4EAE-A761-544F1258147AQ34447986-DCA2EEE4-C2D6-4C90-9969-6ABB432EDC90Q34572820-DF82CC51-A632-4BC2-8AD8-94632EAC7CE6
P2860
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@en
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@nl
type
label
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@en
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@nl
prefLabel
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@en
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@nl
P2093
P921
P1433
P1476
Degradation of fibrillar colla ...... c herpes simplex virus vector.
@en
P2093
George Alexandrakis
John P Zimmer
Numpon Insin
Paola Grandi
Rakesh K Jain
Wilson Mok
Xandra O Breakefield
Yves Boucher
P304
P356
10.1158/0008-5472.CAN-05-2242
P407
P577
2006-03-01T00:00:00Z